Industry-funded studies of breast cancer therapies are more likely to report positive results than non-pharmaceutical funded studies, researchers from the University of North Carolina at Chapel Hill and the Dana Farber Cancer Institute have found.
A team of researchers at the University of Colorado at Boulder has developed a new technique to generate laser-like X-ray beams, removing a major obstacle in the decades-long quest to build a tabletop X-ray laser that could be used for biological and medical imaging.
Seafood allergy sufferers may soon be able to eat prawns without the fear of an adverse reaction. Chinese scientists have taken a promising step towards removing from prawns the proteins that cause an allergic response without resorting to genetic manipulation, reports Lisa Richards in Chemistry & Industry, the magazine of the SCI.
Corin Group PLC confirms that at the FDA Advisory Panel Meeting, the Panel voted to recommend FDA approval with conditions of Corin?s hip resurfacing device, Cormet, for use in the USA.
Heavy drinking among university students appears to be a universal problem. Although most universities have alcohol policies, it is unclear which interventions can effectively reduce alcohol consumption. A new Swedish study indicates that students who engage in high-risk alcohol consumption benefit the most from a skills-training program.
The Medical University of South Carolina, (MUSC) was recognized for participating in an American Heart Association and American Stroke Association program called Get With the Guidelines.
Every day for 10 years, a seemingly heart-healthy 53-year-old woman experienced rapid and irregular heartbeats. She had no personal or family history of hypertension or hyperthyroidism.
Approval of Focetria, an immune enhancing pandemic influenza vaccine, would allow for more rapid response in the event of influenza pandemic.
In a move to build more consistent cancer care across the country, a collaboration of provinces and territories is introducing a national, interim process for the review of cancer drugs.
Mayo Clinic has collaborated with Digital Cyclone, Inc., a Minnesota-based subsidiary of Garmin, Ltd., to launch a software application that delivers an array of health information and tools directly to cellular phones.